Description

Clopidogrel Camphorsulfonate is a key pharmaceutical salt form of the widely used antiplatelet agent, clopidogrel. This specific salt, with CAS number 120202-68-8, is engineered to enhance the stability, solubility, and bioavailability of the active pharmaceutical ingredient (API) for optimal therapeutic performance. It is an essential intermediate and final form used in the production of cardiovascular medications, primarily targeting the prevention of thrombotic events such as heart attacks and strokes. Pharmaceutical manufacturers and advanced R&D facilities rely on this high-purity compound for the development and production of finished dosage forms.

Application

• Active Pharmaceutical Ingredient (API) Synthesis: Primary use as the final salt form in the manufacturing of clopidogrel-based cardiovascular drugs.
• Formulation Development: Critical for developing stable and bioavailable oral solid dosage forms, such as tablets and capsules.
• Generic Drug Production: A vital raw material for manufacturers producing generic versions of antiplatelet medications post-patent expiry.
• Pharmaceutical Research: Used in preclinical and clinical studies for evaluating new drug delivery systems and combination therapies.
• Quality Control & Reference Standards: Serves as a high-purity reference standard for analytical testing and method validation in QC laboratories.
• Cardiovascular Disease Treatment: The final drug substance used in medicines prescribed for atherosclerosis, acute coronary syndrome, and post-stent placement to prevent blood clots.

Basic Information

Product Name	Clopidogrel Camphorsulfonate
CAS No.	120202-68-8
Molecular Formula	C28H34ClNO6S
Molecular Weight	548.09 g/mol
Synonyms	Clopidogrel (+)-Camphorsulfonate Salt; Clopidogrel Camphorsulfonate Salt; (S)-(+)-Clopidogrel Camphorsulfonate; Clopidogrel Hydrogen (+)-Camphorsulfonate; Methyl (S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate (+)-Camphorsulfonate; SR 25989C; PCR 4099 Camphorsulfonate
EINECS	Contact for details

Quality Control

Our Clopidogrel Camphorsulfonate is manufactured under strict quality management systems, targeting compliance with ICH Q7 guidelines and current Good Manufacturing Practices (cGMP). Each batch undergoes comprehensive analytical testing, including chiral purity verification, to ensure it meets stringent pharmaceutical-grade specifications. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting identity, purity, impurity profile, and residual solvents.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Chiral Purity (Enantiomeric Excess)	≥ 99.5%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Individual impurity: ≤ 0.5% Total impurities: ≤ 1.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.